In a report released yesterday, Michael Craig Jones from Stifel Nicolaus maintained a Hold rating on Agilon Health (AGL – Research Report), with a price target of $7.00. The company’s shares closed yesterday at $4.83.
According to TipRanks, Craig Jones is an analyst with an average return of -4.5% and a 37.50% success rate. Craig Jones covers the Healthcare sector, focusing on stocks such as Agilon Health, Astrana Health, and Alignment Healthcare.
Currently, the analyst consensus on Agilon Health is a Moderate Buy with an average price target of $7.36, implying a 52.38% upside from current levels. In a report released on April 22, Citi also initiated coverage with a Hold rating on the stock with a $6.00 price target.
AGL market cap is currently $2.04B and has a P/E ratio of -9.35.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Agilon Health (AGL) Company Description:
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
